Digitisation | August 05, 2021
Clarivate acquires Bioinfogate
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
It is part of the company’s pain/analgesics portfolio of OTC products
Nureca Ltd has reported financial results for the period ended June 30, 2021.
Complementary business models are the reason for the acquisition
Turnover of API division of ISLL stood at Rs 856.58 crore
The company posted net profit of Rs.9.06 crores for the period ended June 30, 2020.
The company is confident of commencing production at both Mahad and Chiplun units soon
The company proposes to utilise the net proceeds from the fresh issue towards payment of outstanding purchase consideration
The company confirms an upward revision to its 2021 Outlook, reflecting the expectation to achieve mid-teens CER sales growth
Q1 FY22 consolidated revenue grew 6% to Rs. 1,808 crore from Rs. 1,712 crore in Q1 FY21. Q1 FY22 Net Profit was Rs. 84 crore (vs. Rs. 149 crore in Q1 FY21).
Subscribe To Our Newsletter & Stay Updated
